The Latest Cardiac and Vascular News
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that results from the Benefit of Microcore in Acute Decompensated Heart Failure (BMAD) Trial were presented today by Dr. John Boehmer, MD, of Penn State Health Milton S. Hershey Medical Center and the […]
NEW ORLEANS, March 6, 2023 — Edwards Lifesciences (NYSE: EW) today highlighted new important data examining mortality rates and cardiac damage of early-stage aortic stenosis (AS) sufferers, along with data examining 10-year transcatheter aortic valve replacement (TAVR) re-intervention rates using real-world Medicare data. Together these studies, presented at the American College […]
Preliminary results of large-scale real-world data study of Medicare patients conclude that use of intravascular imaging (IVI) during percutaneous coronary intervention (PCI) procedures grew 62% between 2013 and 2019, and is associated with lower incidence of mortality, acute myocardial infarction (MI), repeat PCI, and major adverse cardiac event (MACE) […]
Solutions enable care teams to enhance cross-specialty provider workflows leading to decreased time to treatment and improved transfers NEW YORK, March 4, 2023 /PRNewswire/ — Aidoc, the leading provider of healthcare AI solutions, today launched its premier, first-of-its-kind cardiovascular AI solutions package during the opening of the American College of Cardiology (ACC) 2023 annual […]
New five-year data presented at American College of Cardiology Scientific Sessions (ACC.23) and simultaneously published in The New England Journal of Medicine reinforce the long-term safety and effectiveness of MitraClip for treating secondary mitral regurgitation (MR) Results show minimally invasive mitral valve repair in advanced heart failure patients reduces hospitalizations and deaths […]
– Both the NODE-303 and RAPID-extension studies are complete – Following FDA feedback, Etripamil NDA is on-track for submission in the third quarter of 2023 – Potential to be the first fast-acting, patient administered treatment to break PSVT episodes if approved MONTREAL and CHARLOTTE, N.C., March 6, 2023 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company […]
–In Vitro Data Presentations Support Antithrombotic and Antioxidant Effects of EPA Compared with DHA, No Impact of Mineral Oil on Rates of LDL Oxidation -– DUBLIN, Ireland and BRIDGEWATER, N.J., March 06, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today highlighted new in vitro data supporting the potential mechanistic effects […]
Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive HCM, Supporting Advancement to Phase 3 Additional Results from FOREST-HCM Demonstrate Long-Term Treatment with Aficamten for 48 Weeks is Well-Tolerated and Associated with Sustained Treatment Effect Company to Host Investor Event and Conference […]
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEXLETOL Significantly Reduced Risk of Major Adverse Cardiovascular Events (MACE-4) and (MACE-3) by 13% (P=0.004) and 15% (P=0.006), Respectively, and Significantly Reduced Risk of Myocardial Infarction by 23% (P=0.002) […]
Emphasizes challenges faced by patients and clinicians within the first 30 days after discharge from a heart failure hospitalization Reinforces impact of rehospitalizations for heart failure patients and healthcare system Campaign launches at American College of Cardiology’s 72nd Annual Scientific Session Together with World Congress of Cardiology THE WOODLANDS, Texas, […]
